Lexicon Pharmaceuticals
LXRX
#6663
Rank
NZ$1.17 B
Marketcap
NZ$2.78
Share price
-3.05%
Change (1 day)
222.19%
Change (1 year)

Lexicon Pharmaceuticals (LXRX) - Net assets

Net assets on the balance sheet as of September 2025 : NZ$0.21 Billion

According to Lexicon Pharmaceuticals 's latest financial reports the company has NZ$0.21 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Lexicon Pharmaceuticals - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$NZ$0.25 B75.77%
2023-12-31$NZ$0.14 B-20.19%
2022-12-31$NZ$0.18 B10.92%
2021-12-31$NZ$0.16 B-23.26%
2020-12-31$NZ$0.21 B24.64%
2019-12-31$NZ$0.17 B-541.7%
2018-12-31$-NZ$39.37 Million-140.95%
2017-12-31$NZ$96.12 M-57.7%
2016-12-31$NZ$0.22 B-45.59%
2015-12-31$NZ$0.41 B15.22%
2014-12-31$NZ$0.36 B75.06%
2013-12-31$NZ$0.20 B-36.12%
2012-12-31$NZ$0.32 B-14.98%
2011-12-31$NZ$0.38 B19.08%
2010-12-31$NZ$0.32 B42.24%
2009-12-31$NZ$0.22 B-33.29%
2008-12-31$NZ$0.33 B-9.8%
2007-12-31$NZ$0.37 B208.26%
2006-12-31$NZ$0.12 B-3.32%
2005-12-31$NZ$0.12 B-26.33%
2004-12-31$NZ$0.17 B-33.36%
2003-12-31$NZ$0.25 B-21.24%
2002-12-31$NZ$0.32 B-38.27%
2001-12-31$NZ$0.52 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Thermo Fisher Scientific
TMO
NZ$93.73 B 44,454.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$4.76 B 2,166.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
NZ$54.72 B 25,912.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-NZ$0.13 Billion-160.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$1.78 B 746.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-NZ$0.8 Billion-475.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-NZ$0.29 Billion-236.47%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$10.65 B 4,965.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
NZ$6.25 M-97.03%๐Ÿ‡บ๐Ÿ‡ธ USA